Heyman Richard A. bought ORIC
July 24, 2026 · Form 4 insider transaction
Heyman Richard A. bought 3,500 shares of ORIC Pharmaceuticals, Inc. at $1.60 per share, a transaction worth $5.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,500
Price
$1.60
Total value
$5.6K
InsiderHeyman Richard A.
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 24, 2026
Filing dateJuly 28, 2026
Shares owned after45,300
OwnershipDirect
10b5-1 planNo
AmendedNo